ERDAFITINIB vs ERENUMAB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
ERDAFITINIB vs ERENUMAB: Safety Overview
| Metric | ERDAFITINIB | ERENUMAB |
|---|---|---|
| Total FAERS Reports | 1,106 | 1,183 |
| Deaths Reported | 315 | 363 |
| Death Rate | 28.5% | 30.7% |
| Hospitalizations | 226 | 498 |
| Average Patient Age | 66.6 yrs | 45.6 yrs |
| % Female Patients | 37.9% | 93.4% |
| FDA Approval Date | Apr 12, 2019 | N/A |
| Manufacturer | Janssen Products LP | Amgen Inc |
| Route | ORAL | SUBCUTANEOUS |
| Marketing Status | Prescription | N/A |